Medical Journals

Immunogenicity of Mycobacterium Bovis Bcg Expressing Anaplasma Marginale Msp1a Antigen.

Authors:
  • Michelon André
  • Conceição Fabricio Rochedo
  • Binsfeld Pedro Canisio
  • da Cunha Cristina Wetzel
  • Moreira Angela Nunes
  • Argondizzo Ana Paula
  • McIntosh Douglas
  • Armôa Geraldo R G
  • Campos Adriano S
  • Farber Marisa
  • McFadden Johnjoe
  • Dellagostin Odir Antônio

From: Centro de Biotecnologia, Universidade Federal de Pelotas, CP 354, 96010-900 Pelotas, RS, Brazil.

Vaccine

  • Publish Date: Sep 2006
  • ISSN: 0264-410X
  • Volume: 24
  • Issue: 37-39
  • Pages: 6332-9
  • Medium: Print
  • Language: English
  • Citation (JAMA): Michelon André, Conceição Fabricio Rochedo, Binsfeld Pedro Canisio, et al. Immunogenicity of Mycobacterium Bovis Bcg Expressing Anaplasma Marginale Msp1a Antigen.. Vaccine Sep 2006;24:6332-9

Abstract

Humoral and cellular immune responses of mice inoculated with recombinant Mycobacterium bovis BCG expressing the MSP1a antigen of Anaplasma marginale were evaluated. The msp1a gene was amplified by PCR and cloned into the mycobacterial expression vectors pUS2000 and pMIP12. Immunization of isogenic BALB/c mice with the rBCG/pUS2000-msp1a construct induced significant seroconversion to MSP1a (p<0.001), which was 26 times above pre-immunization levels at day 63 post-initial immunization and which remained stable for the duration of the experiment (6 months). In contrast, rBCG/pMIP12-msp1a induced seroconversion at a level of 6 times above pre-immunization values, which peaked at day 63. Western blot analysis showed that sera derived from mice vaccinated with either rBCG construct recognized both native and recombinant forms of A. marginale MSP1a. In contrast to the humoral response data, immunization with rBCG/pMIP12-msp1a was found to induce a markedly stronger cellular response than that recorded for BCG/pUS2000-msp1a. These observations clearly demonstrated the immunogenicity of recombinant BCG expressing the MSP1a antigen and suggested that the immune responses were influenced by the level of antigen expression. The results of this research warrant studies of recombinant M. bovis BCG expressing MSP1a in cattle to test for protective antibody production for control of bovine anaplasmosis.

Mesh Headings (Keywords): Anaplasma marginale, Animals, Antibody Formation, BCG Vaccine, Bacterial Outer Membrane Proteins, Cattle, Cloning, Molecular, Female, Immunity, Cellular, Mice, Mice, Inbred BALB C, Mycobacterium bovis


Check for Full Text / PubMed Unique Identifier (PMID): 16781025


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.